Status
Conditions
About
Massive prostheses are the standard treatment for extensive bone loss, whether caused by cancer or other factors (complex fractures, multiple revisions, infections).
The emergence of modular systems such as the Pantheon range provides rapid restoration of function and precise intraoperative adaptation to anatomical constraints and specific bone loss characteristics.
The Pantheon range also offers an innovative intramedullary ring system that promotes osseointegration and potentially long-term mechanical stability of implants.
However, few studies have evaluated its clinical efficacy. In this context, a prospective cohort study is warranted in order to obtain robust data on implant survival, patient quality of life and predictors of medium- and long-term complications.
Full description
The IMPULSION study is an observational study. The primary objective is to evaluate prosthesis survival within 5 years post-operatively.
The secondary objectives are: to evaluate functional outcomes, quality of life, the occurrence of complications, and the osseointegration of the intramedullary ring.
Patients are included during the consultation to plan the surgery. Following surgery, the patient is followed up at 1 year, 2 years and 5 years post-operatively.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Implants from the Pantheon prosthesis:
Proximal Femur Recontruction (PFR) Distal Femur Reconstruction (DFR) Proximal Tibia Reconstruction (PTR) Total Femur Reconstruction (TFR) Hybrid connector implants Custom-made implants
Exclusion criteria
375 participants in 1 patient group
Loading...
Central trial contact
Vincent CRENN, Pr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal